GLP-1 Receptor Agonists and Magnesium Deficiency: A Hidden Connection
The Impact of GLP-1 Medications on Nutritional Balance
GLP-1 receptor agonists, such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), have revolutionized the treatment of obesity and type 2 diabetes. These medications work by regulating blood glucose levels, slowing stomach emptying, and suppressing appetite. However, their effectiveness comes with a hidden cost: a risk of magnesium deficiency. Magnesium is an essential mineral involved in over 300 enzymatic reactions, including energy production, muscle function, and nerve function. It also plays a crucial role in maintaining healthy blood sugar levels and preventing cardiovascular disease. However, GLP-1 receptor agonists can interfere with magnesium levels in several ways, leading to a potentially severe deficiency.Understanding the Relationship between GLP-1 and Magnesium
